Tags

Type your tag names separated by a space and hit enter

Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians.

Abstract

One of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported.

Authors+Show Affiliations

American College of Physicians, Philadelphia, Pennsylvania (A.Q.).Minneapolis VA Medical Center, Minneapolis, Minnesota (T.J.W.).No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31426089

Citation

Qaseem, Amir, et al. "Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians." Annals of Internal Medicine, 2019.
Qaseem A, Wilt TJ, Clinical Guidelines Committee of the American College of Physicians. Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2019.
Qaseem, A., & Wilt, T. J. (2019). Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians. Annals of Internal Medicine, doi:10.7326/M18-3279.
Qaseem A, Wilt TJ, Clinical Guidelines Committee of the American College of Physicians. Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2019 Aug 20; PubMed PMID: 31426089.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Disclosure of Interests and Management of Conflicts of Interest in Clinical Guidelines and Guidance Statements: Methods From the Clinical Guidelines Committee of the American College of Physicians. AU - Qaseem,Amir, AU - Wilt,Timothy J, AU - ,, Y1 - 2019/08/20/ PY - 2019/8/20/entrez PY - 2019/8/20/pubmed PY - 2019/8/20/medline JF - Annals of internal medicine JO - Ann. Intern. Med. N2 - One of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported. SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/31426089/Disclosure_of_Interests_and_Management_of_Conflicts_of_Interest_in_Clinical_Guidelines_and_Guidance_Statements:_Methods_From_the_Clinical_Guidelines_Committee_of_the_American_College_of_Physicians L2 - https://www.annals.org/article.aspx?doi=10.7326/M18-3279 DB - PRIME DP - Unbound Medicine ER -